• α-Bungarotoxin for Nicotinic Receptor Blockade

  2026-08-17

  Use α-Bungarotoxin to convert α7 nAChR activation from an assumption into a testable experimental variable across neuronal, neuromuscular, and placental models. This guide combines receptor-blockade workflows, pathway-level controls, assay optimization, and troubleshooting for cholinergic signaling studies.

• 3X FLAG Peptide for Translational Mechanism

  2026-08-16

  Mechanistic studies of CDK4, 4E-BP1, and mTOR inhibitor resistance require more than a phosphorylation signal: they require confident protein recovery, identity confirmation, and functional follow-through. This thought-leadership guide explains how the 3X (DYKDDDDK) Peptide can strengthen FLAG-based assay architecture while preserving a disciplined connection between chemoproteomic discovery and translational validation.

• Chlorin e6: PDT Workflows and Optimization

  2026-08-15

  Chlorin e6 supports controllable ROS-based experiments spanning cancer-cell photodynamic therapy and antibacterial wound-material research. This workflow-focused guide connects free Ce6 dosing, light calibration, apoptosis assays, and Ce6-functionalized silk fibroin scaffolds while emphasizing controls and troubleshooting.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-14

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is intended for resolving low-molecular-weight proteins and peptides that may be poorly separated by conventional Tris-SDS-PAGE. It supports research workflows including denaturing and non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.

• Sodium Nitroprusside in Vascular Assays

  2026-08-14

  Use Sodium Nitroprusside as a controlled nitric oxide donor challenge to separate vascular smooth muscle responsiveness from upstream hypertension mechanisms. This practical guide connects sex-stratified angiotensin II research with tissue, platelet, and integrated assay workflows, including preparation parameters and troubleshooting strategies.

• Tamoxifen and PINK1: Designing Better Cancer Assays

  2026-08-13

  Tamoxifen is more than a selective estrogen receptor modulator: in conditional genetics, it can shape the biological readouts researchers measure. This article explains how to use Tamoxifen CreER-mediated gene knockout models to interrogate PINK1, mitochondrial iron, autophagy, and tumorigenesis without confusing induction effects with disease biology.

• FAK Inhibitor 14: Applied Research Workflows

  2026-08-13

  FAK Inhibitor 14 enables pharmacological interrogation of FAK/Src signaling in migration, EMT, and cholesterol-adapted ovarian cancer models. This guide combines practical dosing, pathway-level readouts, comparative assay design, and troubleshooting for reproducible cancer biology research.

• Radicicol Workflows for Hsp90 and Metabolic Research

  2026-08-12

  Radicicol is a versatile Hsp90 inhibitor for connecting protein-quality control with adipogenesis, apoptosis, inflammation, and antigen cross-presentation assays. This guide converts its pharmacology into practical dose-finding, control design, nanoparticle studies, and troubleshooting workflows.

• Z-LEHD-FMK: From Apoptosis to Translation

  2026-08-12

  A thought-leadership guide to using Z-LEHD-FMK as an irreversible caspase-9 inhibitor for causal pathway dissection, time-resolved apoptosis assays, cancer research, and neuroprotection in spinal cord injury. The article connects mitochondrial apoptosis biology with translational study design, emphasizing orthogonal readouts, model-specific controls, and the limits of extrapolating cytoprotection into therapeutic claims.

• Ginsenoside Rg1 as a Gut–Brain Assay Probe

  2026-08-11

  Ginsenoside Rg1 is a Panax-derived triterpene saponin that offers more than a neuroprotective phenotype: it can serve as a mechanistic probe of gut–immune–brain communication. This article explains how to design, control, and interpret Rg1 experiments using causal immune validation rather than single-endpoint outcome measures.

• Atorvastatin: From Mevalonate Flux to Ferroptosis

  2026-08-11

  Atorvastatin is an HMG-CoA reductase inhibitor with applications extending from cholesterol metabolism research to ferroptosis-oriented hepatocellular carcinoma studies. This guide explains how to connect pathway perturbation, cell-state biology, and assay design without overinterpreting model-specific results.

• Z-WEHD-FMK: Mapping Caspase-1 to Pyroptosis

  2026-08-10

  A translational perspective on how Z-WEHD-FMK and Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK can help researchers connect inflammatory caspase activity with pyroptosis, Golgi remodeling, infection biology, and cancer mechanism.

• Ethacridine Lactate Monohydrate in Cell Assays

  2026-08-09

  Learn how to use Ethacridine lactate monohydrate as a research-use antiseptic agent for microbial control without confusing contamination management with a biological mechanism. The workflow connects disciplined sterility testing with YAP-TEAD and super-enhancer assays, emphasizing vehicle controls, cell-compatibility pilots, and fresh solution handling.

• Multiomics Maps Acute Liver Injury Drug Responses

  2026-08-08

  The reference study combines co-expression modules, regulatory analysis, transcriptomics, and proteomics to compare bifendate with muaddil sapra in CCl4-induced acute liver injury. Its main contribution is a systems-level map showing partly shared but mechanistically distinct treatment responses, while also identifying candidate transcriptional, noncoding-RNA, and protein regulators for future validation.

• Laminin (925-933): An Assay Design Framework

  2026-08-07

  Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-mediated adhesion from chemotaxis and downstream phenotype. This article develops an evidence-based workflow that connects peptide assay design with lessons from human brain-slice and tau pathology research.

539 records 7/36 page Previous Next First page 上5页 678910 下5页 Last page